Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich water alleviates constipation by attenuating oxidative stress through the sirtuin1/nuclear factor-erythroid-2-related factor 2/heme oxygenase-1 signaling pathway

Chen KD, Wang KL, Chen C, Zhu YJ, Tang WW, Wang YJ, Chen ZP, He LH, Chen YG, Zhang W. · World J Gastroenterol. 2024;30(20):2709–2725.

PreclinicalH₂-rich waterPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat study

Research topic

Gastrointestinal health

Administration classification

H₂-rich water

Study result signal

Mixed positive preclinical signal.

Outcome type

Functional, tissue, microbiome, metabolomic and biomarker outcomes in rats.

Reported in the source

Methods at a glance

Population or model

Male Sprague-Dawley rats in a loperamide-induced constipation model.

Sample

18 rats; three groups of six.

Duration

Seven days of H₂-water during a 14-day model protocol.

Intervention

Hydrogen-rich water by gavage on days 8–14.

Hydrogen form

H₂ dissolved in drinking water.

H₂ specification

Greater than 3 ppm dissolved H₂; 3 mL per administration.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Untreated control and loperamide model groups.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Stool measures, intestinal transit, histology, microbiome, serum metabolites and oxidative markers.

Reported result

Several stool, transit, tissue, microbial, metabolomic and oxidative measures favored hydrogen-rich water, while not every measured feature differed.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small animal study with high-dimensional exploratory analyses; product was supplied to the investigators.

Applies directly to

The reported loperamide rat model only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Small groups, many outcomes and unclear concealment and assessor blinding.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 38855154 · DOI: 10.3748/wjg.v30.i20.2709

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10